Following the elucidation of the molecular basis of the circadian clock in the past 25 years, these empirical approaches have been, to some extent, replaced by mechanism-based attempts to treat diseases ranging from bronchial asthma to lung cancer, colorectal cancer, and glioblastoma (22, 23). Here, CLOCK is linked to glioblastoma.